ROSA DAVID A (CEO and President) purchased 9.4% of their position (100K shares) of NEUROONE MEDICAL TECHNOLOGIES CORP on the open market
Open‑market purchase worth $50.0K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 4/7/2025ACC: 0001540354-25-000004
DirectorOfficer· CEO and President
Since Feb 2026
+100K
Net shares
Net buyer
$50.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
100K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+100K
Price / share
$0.50
Trade value
$50K
% of position
9.4%
4/4/2025
1.06M→1.16M
Total
Net shares
+100K
Net value
$50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/4/2025 | P · Purchase | +100K | $0.50 | $50K | 9.4% | 1.06M | 1.16M |
| Total | +100K | $50K | ||||||
Derivative Transactions0
No derivative transactions reported